Giulia Bianchi
- Oncology top 0.2%
- HER2/EGFR in Cancer Research 39
- Cancer Treatment and Pharmacology 26
- Cancer Cells and Metastasis 9
- Cancer Immunotherapy and Biomarkers 9
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies 32
- Cancer Genomics and Diagnostics 15
-
- Monoclonal and Polyclonal Antibodies Research 16
-
- Advanced Breast Cancer Therapies 30
- Genetics top 2%
Giulia Bianchi
120 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 4.8k
- Cancer Research 2.2k
- Radiology, Nuclear Medicine and Imaging 1.8k
- Pulmonary and Respiratory Medicine 1.6k
- Genetics 435
Countries citing papers authored by Giulia Bianchi
This map shows the geographic impact of Giulia Bianchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Bianchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Bianchi more than expected).
Fields of papers citing papers by Giulia Bianchi
This network shows the impact of papers produced by Giulia Bianchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Bianchi. The network helps show where Giulia Bianchi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Giulia Bianchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 16 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 33 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 16 | |
| 9 | 2022 | 8 | |
| 10 | 2020 | 7 | |
| 11 | 2020 | 27 | |
| 12 | 2020 | 2 | |
| 13 | 2020 | 1 | |
| 14 | 2019 | 2 | |
| 15 | 2017 | 1 | |
| 16 | 2017 | 19 | |
| 17 | 2016 | 30 | |
| 18 | 2014 | 4 | |
| 19 | 2013 | 302 | |
| 20 | Pilot trial of trastuzumab starting with or after the doxorubicin component of a doxorubicin plus paclitaxel regimen for women with HER2-positive advanced breast cancer. | 2003 | 41 |
About Giulia Bianchi
Giulia Bianchi is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Otorhinolaryngology, having authored 127 papers that have together received 6.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (39 papers), Breast Cancer Treatment Studies (32 papers), Advanced Breast Cancer Therapies (30 papers), Cancer Treatment and Pharmacology (26 papers), Monoclonal and Polyclonal Antibodies Research (16 papers), Cancer Genomics and Diagnostics (15 papers), Cancer Cells and Metastasis (9 papers) and Cancer Immunotherapy and Biomarkers (9 papers). The work is most often cited by research in Oncology (4.8k citations), Cancer Research (2.2k citations), Radiology, Nuclear Medicine and Imaging (1.8k citations), Pulmonary and Respiratory Medicine (1.6k citations) and Genetics (435 citations). Giulia Bianchi has collaborated with scholars based in Italy, Spain and United States. Frequent co-authors include Luca Gianni, Graham Ross, Semiglazov Vf, Aňa Lluch, Pinuccia Valagussa, Tadeusz Pieńkowski, Ling‐Ming Tseng, Young‐Hyuck Im, Juan de la Haba-Rodríguez and Brigitte Poirier. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Clinical Breast Cancer and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.